other

Updated:

Seisa Medical

Julio Chiu founded Seisa Medical in 1983; the contract manufacturer of Class II/III devices employs 2,500 across four continents.

Seisa Medical

Julio Chiu founded Seisa Medical in 1983 in El Paso, Texas, with an original plant on the US-Mexico border (per the firm). The company has grown organically and through strategic acquisitions — adding injection molding, extrusion, and product design capabilities — to become a full-service contract manufacturer of Class II and Class III medical devices and specialty components. Seisa manufactures implantable stents, catheter-based products, tubing sets, and pediatric and orthopedic-care items across its global facilities. The firm’s asset-class mix encompasses product design and development, 510K regulatory support, medical device prototyping, injection molding, extrusion, laser cutting and welding, nitinol and specialty alloy processing, CNC machining, EDM, wire forming, and mold making. Seisa targets the entire medical device product life cycle, from prototype through final assembly and packaging. Confirmed capabilities include FDA registered products and ISO 13485 compliant operations. The company operates manufacturing locations in North America (El Paso and Ciudad Juarez; Eatontown, New Jersey; Bay Area, California) and Europe (Myjava, Slovak Republic). Seisa employs approximately 2,500 employees and operates more than 350,000 square feet of manufacturing space, including 150,000 square feet of class 7 and 8 cleanroom capacity. Adjacent vehicles include the BioMed Cluster, a cross-border initiative on whose board Julio Chiu serves as president, aimed at boosting the El Paso-Juarez region’s competitiveness in medical manufacturing. The company also maintains a website blog and news/events section. Seisa’s structural differentiator is its vertical integration: through acquisitions and investments, the firm has absorbed each step of the manufacturing process — from prototype to production technologies — so that a single contractor can handle the full supply chain for implantable and specialty medical devices. The mandate remains tightly focused on precision contract manufacturing; Seisa does not operate as a venture investor or RIA.

Website
seisa.com

General information

Firm type

other

Year founded

1983

AUM

Undisclosed

Location

Region

North America

Country

United States

City

El Paso

Corporate office

El Paso, TX, United States

Additional offices

Ciudad Juarez, Mexico · Eatontown, NJ, United States · Myjava, Slovak Republic · Bay Area, CA, United States

Principals

Julio Chiu

Founder, CEO and Chairman of the Board

Sector focus

Medical DevicesHealthcare Services

Frequently asked questions

Who runs investment decisions at Seisa Medical?

Julio Chiu is the founder, CEO, and Chairman of the Board. The firm does not disclose a separate investment committee or chief investment officer; capital allocation decisions are made at the executive level within the manufacturing business (per firm website).

How does Seisa source proprietary deal flow?

Seisa does not operate as a venture capital firm or family office investment vehicle. It sources its manufacturing contracts through direct relationships with medical device companies seeking a contract manufacturer for Class II and III devices (per firm website).

Is Seisa Medical structured as a single family office or does it operate more like a venture firm?

Seisa Medical is a contract manufacturing company, not a family office or venture firm. The firm's public profile describes a vertically integrated manufacturer of medical devices with no disclosure of any separate investment portfolio or SFO/MFO structure.

Does Seisa participate in fund commitments or only direct deals?

Seisa does not describe itself as a fund investor. It provides direct contract manufacturing services to medical device customers; there is no public record of fund commitments or indirect investment vehicles attached to the firm (per firm website).

What investment stages does Seisa Medical typically target?

Seisa targets the entire product life cycle of medical devices — from concept and FDA 510K regulatory submission through prototype, manufacturing, final assembly, and packaging. The firm does not disclose early-stage venture investment activity (per firm website).

Which sectors does Seisa Medical explicitly avoid?

Seisa does not publicly list excluded sectors. Its stated focus is Class II and III medical devices and specialty components, with no mention of pharmaceutical, biotech, or non-medical manufacturing (per firm website).

How is Seisa Medical related to the BioMed Cluster?

Julio Chiu serves as board president of the BioMed Cluster, a binational initiative uniting academia, research, and manufacturing firms to promote the El Paso-Juarez region as a global hub for medical manufacturing. Seisa is a founding member of this cluster (per firm website).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo